Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Oculis Holding AG (OCS)

Autolus Therapeutics PLC Sponsored ADR and Oculis Holding AG are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Oculis Holding AG are of similar size ($457.8M and $456.8M). Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 193.3% against 65.8%. Autolus Therapeutics PLC Sponsored ADR has the higher net margin (−238.7% vs −6,870.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Oculis Holding AG leads on 9 and Autolus Therapeutics PLC Sponsored ADR on 7.

Valuation

Metric AUTL OCS Biotechnology median
P/E n/m n/m 8.50
P/S 3.63 303.32 9.71
P/B 5.69 1.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.56 108.92 9.21
Earnings yield (66.25%) (23.87%) (33.15%)
Free cash flow yield (59.62%) (18.51%) (25.50%)

Profitability

Metric AUTL OCS Biotechnology median
Gross margin 15.66% 100.00% 65.16%
Operating margin (210.78%) (7,383.66%) 0.00%
Net margin (238.66%) (6,870.05%) 0.00%
Free cash flow margin (198.26%) (5,525.64%) 0.00%
Return on equity (133.00%) (44.87%) (56.36%)
Return on assets (46.15%) (37.69%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL OCS Biotechnology median
Revenue growth (TTM) 193.29% 65.83% 6.02%
EPS growth (last fiscal year) (25.58%) 5.39% 30.26%
Revenue growth, 5-year CAGR 113.11% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AUTL OCS Biotechnology median
Debt to equity 1.04 0.01 0.00
Current ratio 4.89 8.35 4.72
Net debt to EBITDA 1.16 2.60 0.96

Dividend

Metric AUTL OCS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AUTL OCS Biotechnology median
Market cap 457.80m 456.82m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack